The Challenge of Highly Pathogenic Microorganisms : Mechanisms of Virulence and Novel Medical Countermeasures /

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Shafferman, Avigdor. (Editor), Velan, Baruch. (Editor), Ordentlich, Arie. (Editor)
Format: eBook
Language:English
Published: Dordrecht : Springer Netherlands : Imprint: Springer, 2010.
Edition:1st ed. 2010.
Subjects:
LEADER 04287nam a22004215i 4500
001 000292172
005 20210611140023.0
007 cr nn 008mamaa
008 100623s2010 ne | s |||| 0|eng d
020 |a 9789048190546 
024 7 |a 10.1007/978-90-481-9054-6  |2 doi 
040 |a Sistema de Bibliotecas del Tecnológico de Costa Rica 
245 1 4 |a The Challenge of Highly Pathogenic Microorganisms :  |b Mechanisms of Virulence and Novel Medical Countermeasures /  |c edited by Avigdor Shafferman, Baruch Velan, Arie Ordentlich. 
250 |a 1st ed. 2010. 
260 # # |a Dordrecht :  |b Springer Netherlands :  |b Imprint: Springer,  |c 2010. 
300 |a XVIII, 314 p. :  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
505 0 |a The Anthrax Capsule: Role in Pathogenesis and Target for Vaccines and Therapeutics -- Proteomic Studies of Bacillus anthracis Reveal In Vitro CO2-Modulation and Expression During Infection of Extracellular Proteases -- Dynamics of Bacillus anthracis Infection and Control Mechanisms -- Survival and Trafficking of Yersinia pestis in Non-acidified Phagosomes in Murine Macrophages -- The Inverse Relationship Between Cytotoxicity of Y. pestis and Its Virulence -- The NlpD Lipoprotein of Yersinia pestis is Essential for Cell Separation and Virulence -- Dissection of the Functions of the IglC Protein of Francisella tularensis -- Yersinia pestis Lipopolysaccharide in Host-Pathogen Interactions -- The Interactions Between Pathogens and Dendritic Cells: From Paralysis of Cells to Their Recruitment for Bacterial Colonization -- Comparative Approaches to Identify Host Factors Specifically Targeted by Yersinia pestis During the Infectious Process -- Poxvirus Entry into Host Cells -- Role of A33R Amino-Acid 118L in the Interactions of Vaccinia Virus with the Host -- Inhibitors of Innate Immunity from Vaccinia Virus -- Brucella Species Synchronize Their Life Cycle to the Gestation Cycle of Their Ruminant Hosts -- MMP-9 as a Marker for Vaccinia Virus Related Encephalitis -- Epidemic Cowpox Virus Infections in Germany -- The Two Partner SecretionTwo Partner Secretion Transporters of Yersinia pestis: Cloning, Immunogenicity and In Vivo Expression Following Airway Infection -- Genetic Detection of Vesicle Forming Pathogens by Arrayed Primer Extension (APEX) -- Subtyping Biothreat Bacterial Pathogens -- A Rapid Method for Bacillus anthracis Genotyping -- Tularemia - A Disease with an Uncertain Impact on Public Health -- Consequences of Antibiotic Treatment of Francisella tularensis Airways Infections -- Novel Live Vaccine Candidates Against Airborne Francisella tularensis -- Effect of Disruption of mglA on the Virulence and Immunogenicity of the Francisella tularensis Live Vaccine Strain (LVS) -- Data Mining, Bioinformatic and Immunoinformatic Analyses of Francisella tularensis Schu S4 Genome in Search for Novel Vaccine Candidates -- Modified Vaccinia Virus Ankara (MVA) based Vaccines - Immunostimulatory and Protective Capacity -- Therapeutic Potential of Vaccinia Hyper Immune Sera in Mouse Models of Lethal Orthopoxviruses Infection -- A Live Plaque Vaccine Candidate with Improved Safety and Immunogenecity -- Protection Against Plague Afforded by Treatment with Polyclonal ?LcrV and ?F1 Antibodies -- Combination of Anthrax-Toxin Neutralizing Antibodies: Analysis of Synergism/Antagonism Effect -- The Efficacy of Antibiotic Treatment to Cure Guinea Pigs Intranasally Infected with Bacillus anthracis Spores -- Reverse Vaccinology in Bacillus anthracis Bacillus anthracis . 
650 0 |a Medical microbiology. 
650 0 |a Microbiology. 
650 0 |a Vaccines. 
650 0 |a Bacteriology. 
650 0 |a Microbial genetics. 
650 0 |a Microbial genomics. 
650 1 4 |a Medical Microbiology. 
650 2 4 |a Microbiology. 
650 2 4 |a Vaccine. 
650 2 4 |a Bacteriology. 
650 2 4 |a Eukaryotic Microbiology. 
650 2 4 |a Microbial Genetics and Genomics. 
700 1 |a Shafferman, Avigdor.  |e editor. 
700 1 |a Velan, Baruch.  |e editor. 
700 1 |a Ordentlich, Arie.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
900 |a Libro descargado a ALEPH en bloque (proveniente de proveedor)